ORACLE INVESTMENT MANAGEMENT INC Hedge Fund

CIK: 0001012622 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value ($000): $406,554 (100.0% shares, 0.0% debt)

Holdings (21)

— QUIDEL CORP 26.9%

Value ($000) $109,477 Shares 1,784,464 Est. Cost $25223.83 Unrealized —

— ACCELERATE DIAGNOSTICS INC 19.9%

Value ($000) $80,745 Shares 4,348,140 Est. Cost $22.26 Unrealized —

— AMARIN CORP PLC 18.8%

Value ($000) $76,349 Shares 5,036,220 Est. Cost $603.60 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 18.3%

Value ($000) $74,256 Shares 1,779,875 Est. Cost $46.65 Unrealized —

OPK OPKO HEALTH INC 3.0%

Value ($000) $12,144 Shares 5,810,376 Est. Cost $5.37 Unrealized -62.0%

— DERMIRA INC 2.9%

Value ($000) $11,718 Shares 1,833,785 Est. Cost $12.41 Unrealized —

— MOTUS GI HLDGS INC 1.9%

Value ($000) $7,537 Shares 3,806,666 Est. Cost $3.08 Unrealized —

— SOLENO THERAPEUTICS INC 1.4%

Value ($000) $5,806 Shares 3,870,627 Est. Cost $1.78 Unrealized —

PACB PACIFIC BIOSCIENCES CALIF IN 1.4%

Value ($000) $5,731 Shares 1,110,666 Est. Cost $4.84 Unrealized +15.6%

— VERMILLION INC 1.3%

Value ($000) $5,134 Shares 9,825,289 Est. Cost $1445.80 Unrealized —

— BIOLASE INC 1.2%

Value ($000) $4,863 Shares 5,173,250 Est. Cost $1.21 Unrealized —

— AGENUS INC 1.1%

Value ($000) $4,665 Shares 1,808,296 Est. Cost $2.36 Unrealized —

— BIOHAVEN PHARMACTL HLDG CO L 0.4%

Value ($000) $1,807 Shares 126,400 Est. Cost $46.65 Unrealized —

— CONTRAFECT CORP 0.4%

Value ($000) $1,573 Shares 4,392,713 Est. Cost $2.06 Unrealized —

BIIB BIOGEN INC 0.4%

Value ($000) $1,483 Shares 6,368 Est. Cost $213.68 Unrealized +9.0%

— BIOHAVEN PHARMACTL HLDG CO L 0.2%

Value ($000) $966 Shares 596,000 Est. Cost $46.65 Unrealized —

— ANTARES PHARMA INC 0.2%

Value ($000) $964 Shares 288,237 Est. Cost $3.34 Unrealized —

— ACCELERATE DIAGNOSTICS INC 0.2%

Value ($000) $687 Shares 900,100 Est. Cost $22.26 Unrealized —

— QUIDEL CORP 0.1%

Value ($000) $490 Shares 73,900 Est. Cost $25223.83 Unrealized —

— AMARIN CORP PLC 0.0%

Value ($000) $108 Shares 120,000 Est. Cost $603.60 Unrealized —

XBI SPDR SERIES TRUST 0.0%

Value ($000) $51 Shares 250,000 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	QUIDEL CORP	1,784,464	$109,477	26.9%	$25223.83	—	COM	74838J101
—	ACCELERATE DIAGNOSTICS INC	4,348,140	$80,745	19.9%	$22.26	—	COM	00430H102
—	AMARIN CORP PLC	5,036,220	$76,349	18.8%	$603.60	—	SPONS ADR NEW	023111206
—	BIOHAVEN PHARMACTL HLDG CO L	1,779,875	$74,256	18.3%	$46.65	—	COM	G11196105
OPK	OPKO HEALTH INC	5,810,376	$12,144	3.0%	$5.37	-62.0%	COM	68375N103
—	DERMIRA INC	1,833,785	$11,718	2.9%	$12.41	—	COM	24983L104
—	MOTUS GI HLDGS INC	3,806,666	$7,537	1.9%	$3.08	—	COM	62014P108
—	SOLENO THERAPEUTICS INC	3,870,627	$5,806	1.4%	$1.78	—	COM NEW	834203200
PACB	PACIFIC BIOSCIENCES CALIF IN	1,110,666	$5,731	1.4%	$4.84	+15.6%	COM	69404D108
—	VERMILLION INC	9,825,289	$5,134	1.3%	$1445.80	—	COM NEW	92407M206
—	BIOLASE INC	5,173,250	$4,863	1.2%	$1.21	—	COM NEW	090911207
—	AGENUS INC	1,808,296	$4,665	1.1%	$2.36	—	COM NEW	00847G705
—	BIOHAVEN PHARMACTL HLDG CO L	126,400	$1,807	0.4%	$46.65	—	Put	G11196105
—	CONTRAFECT CORP	4,392,713	$1,573	0.4%	$2.06	—	COM	212326102
BIIB	BIOGEN INC	6,368	$1,483	0.4%	$213.68	+9.0%	COM	09062X103
—	BIOHAVEN PHARMACTL HLDG CO L	596,000	$966	0.2%	$46.65	—	Call	G11196105
—	ANTARES PHARMA INC	288,237	$964	0.2%	$3.34	—	COM	036642106
—	ACCELERATE DIAGNOSTICS INC	900,100	$687	0.2%	$22.26	—	Call	00430H102
—	QUIDEL CORP	73,900	$490	0.1%	$25223.83	—	Call	74838J101
—	AMARIN CORP PLC	120,000	$108	0.0%	$603.60	—	Call	023111206
XBI	SPDR SERIES TRUST	250,000	$51	0.0%	—	—	Call	78464A870